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Mer receptor tyrosine kinase mediates both tethering
and phagocytosis of apoptotic cells
I Dransfield*,1,3, A Zagórska2,3, ED Lew2, K Michail1 and G Lemke2
Billions of inflammatory leukocytes die and are phagocytically cleared each day. This regular renewal facilitates the normal
termination of inflammatory responses, suppressing pro-inflammatory mediators and inducing their anti-inflammatory
counterparts. Here we investigate the role of the receptor tyrosine kinase (RTK) Mer and its ligands Protein S and Gas6 in the
initial recognition and capture of apoptotic cells (ACs) by macrophages. We demonstrate extremely rapid binding kinetics of both
ligands to phosphatidylserine (PtdSer)-displaying ACs, and show that ACs can be co-opsonized with multiple PtdSer opsonins. We
further show that macrophage phagocytosis of ACs opsonized with Mer ligands can occur independently of a requirement for αV
integrins. Finally, we demonstrate a novel role for Mer in the tethering of ACs to the macrophage surface, and show that
Mer-mediated tethering and subsequent AC engulfment can be distinguished by their requirement for Mer kinase activity. Our
results identify Mer as a receptor uniquely capable of both tethering ACs to the macrophage surface and driving their subsequent
internalization.
Cell Death and Disease (2015) 6, e1646; doi:10.1038/cddis.2015.18; published online 19 February 2015
Many diseases, including rheumatoid arthritis, pulmonary
fibrosis, adult respiratory distress syndrome, and inflamma-
tory bowel disease,1–4 are commonly marked by impaired
resolution of inflammation that is linked to defects in the
phagocytic clearance of apoptotic cells.5–7 Apoptotic cell (AC)
clearance normally eliminates a plethora of pro-inflammatory
stimuli,8,9 and the recognition of ACs by phagocytes10 limits
progression to necrosis,11 suppresses pro-inflammatory
mediator production, and induces IL-10 and TGF-β
release.12,13 As defective clearance of ACs is associated with
the development of inflammatory disease and autoimmunity,14,15
new therapeutic approaches designed to increase the
capacity of phagocytes to remove ACs could effectively
promote the resolution of inflammation.
Phagocytosis of ACs can be regulated by solublemediators,
including cytokines,16,17 prostaglandins and lipoxins,17–19
serum proteins,20 agonists of Liver X receptors (LXRs),17,21
and glucocorticoids (GC).17,22 In particular, LXR agonists and
GCs promote phagocytosis of ACs predominantly via a Tyro3/
Axl/Mer (TAM) receptor tyrosine kinase (RTK)-dependent
pathway.17,21,23 There are two established ligands for the
TAM RTKs, Protein S (gene name Pros1), which activates
Tyro3 and Mer, and Gas6, which activates all three TAMs,24,25
although other ligands have been suggested.26,27 The amino
terminal Gla domains of Protein S and Gas6 bind to
phosphatidylserine (PtdSer) on the plasma membrane of
ACs,28 a potent ‘eat-me’ signal by which ACs are recognized
by phagocytes.29 TAM receptors bind to the carboxy terminal
domains of Protein S and Gas6, which effectively act as
molecular ‘bridges’ between PtdSer on the AC and TAM
receptors on the phagocyte.17,30,31 TAM receptor- and ligand-
deficient mice exhibit defective phagocytic pruning of photo-
receptor outer segments by retinal pigment epithelial (RPE)
cells of the eye,32–34 defective clearance of apoptotic germ
cells by Sertoli cells of the testis,35 and defective clearance of
ACs by macrophages/dendritic cells in lymphoid organs.36
These phenotypes are also detectable in Mer (gene name
Mertk) single knockouts.37 In addition to phagocytic clearance,
TAM signaling also has a pivotal role in controlling the innate
immune response to pathogenic stimuli.13,17,38
Although the importance of Mer in the internalization of ACs
by macrophages is now well-established, this receptor has
been thought not to have a significant role in the initial
‘tethering’ of ACs to the macrophage surface.36,39 In their
studies, Scott et al.36 used peritoneal macrophages for which
tethering of ACs has now been shown to be mediated by T-cell
immunoglobulin and mucin domain-containing molecule 4
(TIM4).39 Subsequent internalization of tethered ACs is then
mediated by either integrin αvβ3- or Mer-mediated
signaling.39,40 Similarly, for RPE cells, the initial capture of
photoreceptor outer segments by RPE cells required the
integrin αvβ5,41 with Mer-dependent signaling necessary for
subsequent internalization. To further probe the mechanistic
role of Mer in AC recognition and engulfment, we have now
examined macrophages that predominantly use a Mer-
dependent AC phagocytosis mechanism.17,23 We show that
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in these cells, which do not express TIM4, Mer has the
capacity to serve a unique dual role in mediating both tethering
of ACs to the macrophage surface as well as subsequent AC
engulfment.
Results
Rapid binding of TAM ligands to ACs. Previous studies of
TAM ligand binding to ACs have used indirect labeling
techniques, including FITC-avidin to detect biotinylated
ligand28 or labeled antibodies,23,42 and these studies did
not examine the kinetics of ligand binding. To examine
directly the opsonization of ACs with TAM ligands, we used
flow cytometric analysis of fluorescently labeled Protein S
and Gas6. Labeled full-length Gas6 and Protein S were both
functional, conferring TAM-dependent phagocytosis and
capable of inducing phosphorylation of TAMs (data not
shown). Importantly, fluorophore-labeled TAM ligands were
found to bind to ACs (Figures 1a and b) in a manner consistent
with data from indirect binding studies. Gla domain structure
and PtdSer binding are known to be calcium-dependent43
and, accordingly, TAM ligands exhibited calcium-dependent
binding to apoptotic thymocytes (Figures 1a and b). In contrast,
recombinant Gas6 lacking the Gla domain did not bind to ACs
even in the presence of calcium (Figure 1c). This observation is
consistent with a requirement for the Gla domain for Gas6
binding to immobilized PtdSer44 and demonstrates that the Gla
domain is required for Gas6 binding to ACs.
When apoptotic thymocytes were pre-incubated with
11 nM unlabeled Gas6 before incubation with labeled
Protein S, the extent of subsequent Protein S binding was
not reduced (mean fluorescence of Protein S binding in the
absence of Gas6: 2003±236; in the presence of Gas6:
2110± 380; unlabeled control: 55± 9; mean±S.E.M., n=4).
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Figure 1 TAM ligand binding to apoptotic mouse thymocytes. (a–c) Binding of Dylight-488-labeled TAM ligands (Protein S: human Protein S, Gas6: full-length recombinant
murine Gas6, Gas6-Gla: recombinant murine Gas6 lacking the N-terminal Gla domain) to Dex-treated thymocytes in the presence (solid red line) or absence (dotted blue line) of
1 mM CaCl2. (d) (Upper panels) Representative plots showing dual labeling of apoptotic PMN with Gas6 and Protein S, binding of Cy5-labeled Gas6 only (left) or Dylight-488-
labeled Protein S only (center) or both labeled proteins together (right). (Lower panels) Representative plots showing labeling of apoptotic PMN with PE-labeled AnnexinV only
(left) or with PE-labeled Annexin V, Cy5-labeled Gas6 and Dylight488-labeled Protein S. Plots for Annexin Vand Protein S binding (center) and Annexin Vand Gas6 binding (right)
for the triple labeled cells are shown; data shown are representative of four separate experiments. (e) Representative plots of temporal flow cytometric analysis of Dylight-488
Gas6 and Protein S binding to apoptotic thymocytes. After ~ 30 s of data collection in the absence of ligand, Gas 6 (~15 nM final concentration) or Protein S (25 nM final
concentration) was added and recording continued for ~ 45 s before addition of EDTA (final 5 mM) and recording continued for a further 25–30 s
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Similar results were obtained when ACs were pre-incubated
with 100 nM unlabeled Protein S before addition of labeled
Gas6 (data not shown). We therefore used multi-parameter
flow cytometry to demonstrate that physiological concentra-
tions of Gas6 and Protein S can simultaneously bind to
Annexin V-positive ACs. For this series of experiments, we
used human polymorphonuclear cells (PMN) that had been
cultured in vitro for 20 h, which consistently induces ~70%
apoptosis.6 In dual color labeling experiments, we observed
that Cy5-labeled Gas6 (58 nM) and Dylight488-labeled
Protein S (55 nM) bound to the same subpopulation of cells,
with no reduction in binding when compared with single label
only controls (Figure 1d, top panels). Next, we used three color
flow cytometry to demonstrate that either pre- or co-incubation
with the PtdSer binding protein Annexin V resulted in co-
labeling of ACs with Gas6, Protein S, and Annexin V, whereas
viable Annexin V-negative cells did not bind either Gas6 or
Protein S (Figure 1d, lower panels). Importantly, binding of
Annexin V did not reduce the binding of either Gas6 or Protein
S when compared with single labeled cells: all of the Annexin
V+ cell population in the lower panels of Figure 1d are shifted to
the right following co-addition of Gas6 and Protein S
(Figure 1d, lower panels). This observation indicates that at
~ 50 nM concentrations, the labeled TAM ligands neither
saturate nor compete for available PtdSer sites expressed
on the surface of ACs in this assay (see Discussion). This is
the first demonstration that, in the simultaneous presence of
physiological concentrations of Gas6 and Protein S, both
ligands and other PtdSer-binding proteins can be co-bound to
the AC surface.
Binding of TAM ligands to cells has previously been
examined following relatively long incubation times, followed
by washing and incubation with secondary detection
agents.28,42 In preliminary experiments, complete binding of
labeled TAM ligands occurred following short incubations with
ACs (o5min, data not shown). We undertook a real-time flow
cytometric analysis of labeled Gas6 and Protein S binding
directly to ACs, without washing unbound ligand away
(Figure 1e). Importantly, specific TAM ligand binding occurred
within seconds, reaching near saturation levels of binding
within a minute. Addition of 5 mM EDTA reversed binding
immediately (Figure 1e), an effect that did not involve
quenching of the fluorescence of labeled protein. Rapid
reversal of binding of TAM ligands following the chelation of
extracellular Ca2+ is consistent with Ca2+-dependent binding
of TAM ligands to ACs (Figures 1a and b). Our demonstration
of rapid and specific binding of either TAM ligands to AC
targets suggests that even transient exposure would be
sufficient to mark the AC for clearance by TAM-expressing
phagocytes. Furthermore, the potential for ACs to be
simultaneously opsonized with multiple PtdSer binding proteins
under physiological conditions has significant implications for
the control of AC removal at different tissue sites in vivo.
Mer-dependent phagocytosis of Gas6-opsonized ACs.
As reported previously,17 treatment of bone marrow-derived
macrophages (BMDM) for 24 h with anti-inflammatory GCs
(100 nM dexamethasone (Dex) for 24 h (GC-treated BMDM)
resulted in increased total cellular expression of Mer as
assessed by both immunoblot analysis (Figure 2a) and
surface receptor expression by flow cytometric analysis
(Figure 2b). In contrast, LPS-treated macrophages (100 ng/ml
for 24 h) had very low levels of total and cell surface
expression of Mer (Figures 2a and b). Gas6 serves as a
ligand for all TAM receptors,24,37 and so quantification of
phagocytosis of either unopsonized or Gas6-opsonized AC
targets allows for assessment of TAM-independent and TAM-
dependent phagocytosis. Comparison of the capacity for
TAM-independent phagocytosis (absence of Gas6) of ACs by
macrophage populations revealed that GC-treated BMDM
were relatively inefficient at phagocytosis of ACs when
compared with LPS-treated BMDM (Figure 2c). However, in
the presence of Gas6-opsonized ACs, GC-treated BMDM
become very effective phagocytes, utilizing a predominantly
TAM-dependent AC clearance mechanism (Figure 2c). In
contrast, although LPS-treated BMDM exhibit a significant
augmentation of AC phagocytosis when compared with
untreated BMDM, this phagocytosis is predominantly Gas6-
independent (Figure 2c).
We next examined the utilization of TAM receptors following
combinatorial treatment of BMDM for 24 h with LPS and
different agonists that, like GCs, have been reported to
suppress pro-inflammatory cytokine production,45–47 includ-
ing immune complexes (IgG; 40 μg/ml), sphingosine-1-
phosphate (S1P; 1 μM) and adenosine A2AR agonist
(CGS21680; 10 μM). Combinatorial treatment of BMDM with
LPS and A2AR agonists, S1P, or immune complexes did not
affect the utilization of the largely TAM-independent AC
phagocytosis mechanismwhen compared with LPS treatment
alone (Figure 2d). In contrast, following combinatorial
treatment with LPS and GCs, a marked TAM-dependent
phagocytosis of ACs was observed (Figure 2d). Thus, even in
a pro-inflammatory microenvironment GCs strongly promote
utilization of a predominantly TAM-dependent AC clearance
mechanism.
In addition to Mer, Axl is expressed by BMDM cultures in a
manner that is dependent on activation status.17 To definitively
identify the contribution of Axl and Mer in the phagocytosis of
ACs, we examined Gas6-dependent and independent AC
phagocytosis by GC-treated BMDM derived from wild-type,
Mertk−/−, Axl−/− mice, and Axl−/−/Mertk−/− double-knockout
mice. The gross morphological appearance of BMDM and
surface expression of F4/80 or CD11b was similar for all
genotypes examined, suggesting that macrophage differen-
tiation was not significantly affected by absence of TAMs (data
not shown). GC-treated BMDM from both wild-type and Axl−/−
mice exhibited significant, and similar, Gas6-dependent
phagocytosis of ACs (Figure 3a). The lack of any effect due
to Axl gene deletion is consistent with the fact that GC-treated
BMDM express abundant Mer (Figure 2a), but no little or no
Axl.17 In contrast, GC-treated BMDM prepared from Mertk−/−
or Axl−/−/Mertk−/− mice did not display any increase in
phagocytosis of ACs on addition of Gas6 (Figure 3a). There-
fore, GC-treated BMDM constitute a model in which the bulk of
AC phagocytosis is Mer-dependent.
Integrin-independent AC tethering. Previous studies in
other phagocyte populations have suggested that Mer-
dependent phagocytosis requires integrin-mediated tethering
of ACs.41 We therefore assessed the effects of pre-treatment
Mer-mediated tethering and phagocytosis of ACs
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Figure 3 Mer-dependent phagocytosis of apoptotic cells by GC-treated macrophages. (a) Phagocytosis of pHrodo-labeled apoptotic thymocytes by mouse GC-treated
BMDMwas assessed by flow cytometry. Representative plots showing forward scatter v. pHrodo fluorescence for gated macrophage populations from wild type, Axl−/−,Mertk−/−,
and Axl−/−Mertk−/− mice in the absence (-Gas6) or presence (+Gas6) of 11 nM Gas6. (b) Phagocytosis of apoptotic thymocytes by GC-treated BMDM from either wild type
(black bars) or Axl−/−Mertk−/− (gray bars) mice was assessed by flow cytometry in either the absence, or the presence of Gas6 together with the addition of 1 mM GRGDSP
(RGD), 1 mM GRGESP (RGE), or 10 μg/ml CD61 mAb. Results are presented as the percentage of pHrodo-positive (phagocytic) macrophages (mean±S.D., n= 3)
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Figure 2 Differential regulation of macrophage Mer expression and TAM-dependent phagocytosis of ACs following treatment with LPS or GCs. (a) Determination of total
levels of Mer expression in untreated (UT), LPS-treated (100 ng/ml), or GC-treated (Dex 100 nM) mouse BMDM. Macrophage lysates (10 μg total protein) were separated by
SDS–PAGE, transferred to PVDF membranes, and probed with a Mer antibody and then stripped and re-probed for Gapdh. A representative immunoblot showing upregulation of
Mer expression following GC treatment and downregulation of Mer in response to LPS. (b) Determination of cell surface expression of Mer in untreated (UT), LPS-treated (100 ng/ml), or
GC-treated (Dex 100 nM) BMDM using indirect immunostaining and flow cytometry. A representative histogram overlay for gated macrophage populations is shown to illustrate
upregulation of surface expression of Mer following GC treatment (solid line) and downregulation of Mer following LPS treatment (large dashed line). Binding of non-specific goat
immunoglobulins is also shown (gray profile). (c) Mouse BMDM were treated for 20 h with LPS (100 ng/ml), GCs (Dex 100 nM), or untreated (UT). Macrophage phagocytosis of
pHrodo-labeled apoptotic thymocytes performed without Gas6 (gray bars) or with Gas6 (black bars) was determined by flow cytometric assessment (mean percent
phagocytosis±S.D. is shown, n= 9), as described in the text. (d) Mouse BMDM were treated for 20 h with LPS together with different agonists that have been reported to
suppress LPS effects; immune complexes (IgG; 40 μg/ml), sphingosine-1-phosphate (S1P; 1 μM), adenosine A2AR agonist CGS21680 (A2AR; 10 μM), or Dex (100 nM).
Macrophage phagocytosis of pHrodo-labeled apoptotic thymocytes performed without Gas6 (gray bars) or with Gas6 (black bars) was determined by flow cytometric assessment
(mean percent phagocytosis± S.D. is shown, n= 5)
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of mouse GC-treated BMDM with either GRGDSP peptides
or an integrin β3 (CD61) blocking monoclonal antibody (mAb)
on Gas6-stimulated phagocytosis. We did not observe
inhibition of such phagocytosis by either treatment
(Figure 3b). The function-blocking β3 integrin antibody could
be shown to bind to GC-treated BMDM by flow cytometric
analysis, and the activity of the GRGDSP peptide was
confirmed by detachment of fibroblasts from fibronectin-
coated substrates (data not shown). We further tested
whether phagocytosis of ACs by human monocyte-derived
GC-treated macrophages could be affected by pre-treatment
with blocking antibodies against either β3 integrin or β5
integrin. Pre-treatment of GC macrophages with either mAb
also failed to reduce AC phagocytosis in the presence of
Protein S (control mAb: 68± 4%; β5 mAb: 65±6%, β3 mAb:
67± 8%, mean±S.D., n=3). Together, these data raised the
possibility that phagocytosis of ACs by GC-treated macro-
phages was independent of αV integrin-mediated tethering.
Mer-dependent tethering of ACs to GC-treated macro-
phages. In view of a recent report indicating that TIM4 acts
co-operatively with Mer to mediate tethering of ACs to
peritoneal macrophages,39 we next considered the possibility
that TIM4 was required for phagocytosis of ACs by GC-
treated BMDM. However, we found that unlike peritoneal
macrophages, BMDM do not express TIM4. Mer is strongly
expressed by peritoneal macrophages, and a major sub-
population of these cells expresses TIM4 (Figure 4, upper left
panel). Expression of TIM4 on this peritoneal macrophage
population was not affected by the absence of expression of
Axl and Mer (Figure 4, upper right panel). Although GC-
treated BMDM express Mer (Figures 2a and b, and 4, lower
left panel), they do not express TIM4 (Figure 4, lower panels),
and so this protein cannot have a role in the tethering of ACs
to these cells.
We therefore established an assay to measure tethering of
ACs to the macrophage surface to identify the receptors
involved in this function. We observed significant tethering of
ACs to GC-treated BMDM following co-incubation of ACs
at 4 °C, a temperature at which membrane internalization is
inhibited. We confirmed that under these conditions, GC-
treated BMDM failed to internalize labeled ACs (o2%
internalization), demonstrated by flow cytometric analysis of
macrophages following treatment with trypsin/EDTA to
remove tethered ACs (Figure 5a). Tethering, as opposed to
internalization, of ACs to GC-treated BMDM was further
confirmed by laser scanning confocal microscopy analysis
(Figure 5b). Using the microscopy-based assay we observed
that tethering of ACs to GC-treated BMDM was TAM ligand-
dependent (Figures 5c and d). This suggested that in the GC-
treated BMDM Mer acts as a tethering receptor. Indeed,
macrophage expression of Mer was required for the AC
tethering, as GC-treated BMDM from Mertk−/− animals failed
to show Gas6-dependent tethering of ACs (Figure 5e).
Tethering and engulfment differ in their requirement for
TAM kinase activity. We expected that since Mer tyrosine
kinase activity is significantly inhibited at 4 °C and since
tethering is observed at this temperature, kinase activity
would not be required for Mer-dependent AC tethering. To
test this, we examined the effects of the TAM kinase inhibitor
BMS777607, which we have previously demonstrated is a
potent inhibitor of TAM ligand-induced Axl and Mer
phosphorylation.17,48,49 Although TAM ligand-dependent pha-
gocytosis of ACs was potently blocked by pre-incubation of
GC-treated macrophages with BMS777607,17 AC tethering
was not affected (Figure 5f). These data demonstrate that
tethering is independent of Mer tyrosine kinase activity, but
that Mer-dependent signaling is required for AC internaliza-
tion by macrophages. In a series of experiments to examine
the effects of cytoskeletal disruption using cytochalasin D on
tethering and phagocytosis, we observed that pre-treatment
of GC-treated macrophages with cytochalasin D completely
inhibited both tethering and phagocytosis of ACs (Figure 5f).
These data suggest that the actin cytoskeleton is required for
both Mer-dependent tethering and subsequent phagocytosis.
Mer is a tethering receptor in human GC-treated macro-
phages. Tethering of ACs could be also observed for human
GC-treated macrophages incubated with ACs at 4 °C, as
revealed by scanning electron microscopy (Figure 6a,
arrows). Therefore, we used human monocyte-derived
GC-treated macrophages (which exhibit a higher percentage
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Figure 4 Differential expression of TIM4 on peritoneal and GC-treated
macrophages. Expression of TIM4 and Mer on mouse macrophages was
determined by two-color immunofluorescence analysis. Macrophage populations
from Axl/Mer −/− animals that had been labeled with a Mer antibody were used to
define the threshold for positive staining for Mer, witho1% positive cells. The same
threshold value was then used for equivalent macrophage populations from wild-type
animals. Upper panels: peritoneal cells were collected from untreated mice, and
macrophages were gated on the basis of forward scatter and side scatter.
Representative two-color plots for the expression of Mer and TIM4 on gated
macrophage populations from wild type and Axl−/−Mertk−/− animals, clearly defining
two distinct populations: Mer+/TIM4+ macrophages (~80% of the cells) and
Mer+/TIM4− macrophages (~20% of cells) (upper left panel). The proportions of TIM4+
and TIM4− macrophages is unchanged in peritoneal macrophages obtained from Axl/
Mer−/− animals (upper right panel). Lower panels: mouse GC-treated BMDM were
analyzed for expression of Mer and TIM4. Representative two-color histograms show
expression of Mer and TIM4 on GC-treated macrophages from wild type and
Axl−/−Mertk−/− mice, demonstrating that mouse BMDM lack TIM4 (lower left panel)
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of TAM-dependent phagocytosis when compared with mouse
GC-treated BMDM), to test the prediction that inhibition of
Mer kinase activity with BMS777607 in human GC macro-
phages should result in increased AC tethering. Inhibition of
AC phagocytosis following pre-incubation of human GC-
treated macrophages with BMS777607 was confirmed using
a flow cytometric assay (phagocytosis in the absence of
Protein S; 24+2.6%, Protein S alone; 69+9%, Protein S+
BMS777607; 35.7+7.7%, n=4 Po0.05), consistent with
data from mouse GC-treated BMDM (Figure 5f). To detect
tethering macrophage monolayers were washed multiple
times before quantification of phagocytosis and tethering by
microscopy. For GC-treated macrophages in the absence of
BMS777607, the vast majority of macrophages had inter-
nalized ACs during the 30-min assay, with a small percentage
of tethered ACs (Figure 6b). In contrast, GC-treated macro-
phages incubated with BMS777607 showed increased
tethering of ACs (Figure 6c). Quantification of AC tethering
versus internalization revealed that inhibition of Mer tyrosine
kinase activity resulted in a threefold increase in the
percentage of macrophages with tethered ACs (Figure 6d),
with a concomitant reduction in the percentage of internalized
ACs (Figure 6d). These data demonstrate that in macro-
phages that lack TIM4, Mer can uniquely serve as a receptor
that is required and capable of mediating both tethering and
the subsequent phagocytosis of AC (Figure 7). Mer tyrosine
kinase activity is required for the latter, but not for the former.
Discussion
Wehave identified a novel dual role for theMer RTK in both the
capture (tethering) and subsequent internalization of ACs.
Both of these events require the binding of the Gla domain of a
TAM ligand, either Gas6 or Protein S, to PtdSer expressed on
the surface of ACs. Our data demonstrate that this binding is
rapid and Ca2+-dependent, and is rapidly reversed when Ca2+
is removed. Biochemical analyses have revealed the pre-
sence of multimeric forms of Protein S in plasma,50 and
previous studies have suggested that Protein S may also
undergo oligomerization following binding to phospholipids in
membranes, an event that requires disulfide bond formation.51
Our data indicate that any AC membrane-induced oligomer-
ization of Protein S does not prevent subsequent dissociation
of the ligand on chelation of extracellular calcium.
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Figure 5 Tethering of apoptotic thymocytes to murine GC-treated macrophages. (a) Flow cytometric analysis of the capacity for mouse GC-treated BMDM phagocytosis
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trypsin-EDTA and analysis of fluorescence associated with gated macrophage populations. A typical histogram overlay showing macrophage fluorescence following co-incubation
with labeled thymocytes at 37 °C (solid line) versus 4 °C (dotted line). The fluorescence intensity typically associated with phagocytosis of apoptotic cells is highlighted.
(b) Representative confocal microscopy image showing 45° angle projected composite of serial Z-series images of apoptotic thymocyte (green) tethering to mouse GC-treated
BMDM (red) at 4 °C. Scale bar= 20 μm. (c, d) Tethering of apoptotic targets to mouse GC-treated BMDM. Representative micrographs of tethering of CMFDA-labeled apoptotic
thymocytes (green) to phalloidin-labeled GC-treated BMDM (red) at 4 °C for 30 min in the absence (c) and presence (d) of 11 nM Gas6. Scale bar= 20 μm. (e) GC-treated
BMDM from either wild type or Mertk−/− mice were co-incubated with apoptotic thymocytes at 4 °C in the absence or presence of 11 nM Gas6. Tethering was quantified by
microscopy analysis and the mean percentage of BMDM with tethered ACs was determined, *significant difference (Po0.05) from WT+Gas6 (mean± S.D., n= 5).
Gas6-dependent tethering of apoptotic thymocytes that is observed for wild type GC-treated BMDM is not observed for BMDM derived from Mertk−/− mice. (f) The effect of
pre-treatment of mouse GC-treated BMDM either with BMS777607 (BMS) to block Mer tyrosine kinase activity or with cytochalasin D (CytoD) to disrupt cytoskeletal integrity, on
tethering (grey bars) or phagocytosis (black bars) of apoptotic thymocytes. The percentage of BMDM tethering or phagocytosis was quantified by either microscopy (mean±S.D.,
n= 4) or flow cytometry (n= 3) respectively. *Indicates significant difference (Po0.05) from Gas6 alone
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The simultaneous AC co-binding by physiological concen-
trations of TAM ligands and Annexin V that we document has
important implications for potential co-opsonization of ACs
with multiple PtdSer ligands. Occupancy of all PtdSer binding
sites with ligand requires exceptionally high concentrations of
PtdSer opsonins.28 At physiological concentrations of Protein
S and Gas6, we found that apoptotic thymocytes were able to
bind both ligands simultaneously. One prediction is that under
normal physiological conditions, for ACs that have bound TAM
ligands, additional (unoccupied) PtdSer sites could be
recognized by other PtdSer binding proteins such as MFG-
E820 or C1q52 and could engagemultiple phagocyte clearance
receptors such as TIM4 and BAI1.
Our previously published work,17,23 together with the new
data presented here, unequivocally demonstrate that Mer is
required for TAM ligand-dependent phagocytosis of ACs by
GC-treated BMDM. Axl is not expressed by these cells,17 and
therefore Mer carries the full burden. Although β3 and β5
integrins are expressed by GC-treated macrophages, the lack
of inhibition of TAM-dependent phagocytosis following treat-
ment with RGD containing peptides or function-blocking
antibodies suggests that integrins are not required for AC
phagocytosis by these cells. One of the assays that we have
used further excludes a role for integrins in the tethering of
ACs by GC-treated macrophages, as integrins are likely to be
inactive at 4 °C. In addition, the tethering we observe was
found to be optimal in the presence of Ca2+, not Mn2+.53 Our
findings demonstrate that the two-way communication
between αV integrin and Mer that has been reported in RPE
cells54 does not have a significant role in GC-treated
macrophages.
Peritoneal macrophages express unusually high levels of
TIM4 and are able to tether apoptotic targets via TIM4 without
a requirement for Mer,39,55 but we show that GC-treated
BMDM do not express TIM4 and therefore cannot tether ACs
with this receptor. Although peritoneal macrophages are
widely used for functional analyses, they represent an
unusual population of cells associated with immunity at
serosal surfaces.56 In contrast, there are many phagocytic
tissue macrophage populations in vivo, for example, the
microglia of the central nervous system, that are, like GC-
treated BMDM, strongly Mer-positive but TIM4-negative.57
TIM4 cannot act as a PtdSer receptor in these macrophages.
Recent transcriptome-based analyses reveal that GC-treated
macrophages exhibit considerable overlap with those treated
with IL-10, highlighting the spectrum of macrophage
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Figure 6 Mer-dependent tethering of apoptotic thymocytes to human GC-treated
macrophages. (a) Scanning electron micrograph of apoptotic human PMN (arrowed)
tethering to human monocyte-derived GC-treated macrophages under equivalent
conditions to those used for mouse GC-treated macrophages and apoptotic
thymocytes shown in Figure 5b and d. Scale bar= 10 μm. (b, c) Merged fluorescent/
phase contrast images of human monocyte-derived GC-treated macrophages
incubated with apoptotic human PMN (labeled with CMFDA—green) in the presence
of 35 nM Protein S at 37 °C for 30 min in the absence (b) or presence (c) of 300 nM
BMS777607. Arrows highlight tethering of labeled apoptotic PMN to human
GC-treated macrophages. Scale bar= 20 μm. (d) Quantification of tethering/
phagocytosis of apoptotic PMN by human monocyte-derived GC-treated macro-
phages following co-incubation at 37 °C in the presence of 35 nM Protein S for
30 min. GC-treated macrophages were either DMSO-treated (UT, untreated) or pre-
treated with 300 nM BMS777607. The proportion of GC-treated macrophages, which
showed tethering (gray bars, see Figure 6c) versus phagocytosis (black bars, see
Figure 6b), was determined by microscopy analysis with quantification of at least 500
cells in 5–7 randomly selected fields using a x40 objective. Data shown are
mean±S.D., n= 4
Peritoneal
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Figure 7 Schematic of Mer-mediated tethering and phagocytosis of apoptotic
cells (ACs) in peritoneal versus bone-marrow derived macrophages. The former use
TIM4 for AC tethering and Mer for AC phagocytosis,39 whereas the latter use Mer for
both. Tethering does not require Mer kinase activity, whereas phagocytosis does
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phenotypes that can be identified beyond a simple M1/M2
dichotomy.58 Undoubtedly, the molecular cooperativity
required for the tethering and subsequent clearance of ACs
will be different for different phagocytes.
An interesting recent article suggests that Axl mediates
tethering of AC to dendritic cells,59 supporting the idea that, in
addition to conveying signals that promote internalization,
TAM receptors have an important role in the capture of
apoptotic targets by phagocytes. However, internalization of
ACs tethered via Axl was suggested to require formation of a
molecular complex of Axl and LDL receptor-related protein-1,59
raising the possibility that the mechanism by which Mer and
Axl mediate tethering and internalization of ACs is distinct. Our
data demonstrate that Mer is able to function as a fully
competent AC tethering receptor in GC-treated macrophages,
and can serve the additional function of signaling apoptotic cell
internalization in a TAM tyrosine kinase-dependent manner.
Our results have important implications for the use of TAM
receptor inhibitors, TAM ligands, or antibodies to target TAMs
in vivo, as these different strategies for perturbing TAM
function will exert distinct effects on AC tethering and
phagocytosis. Use of small molecule inhibitors of TAM kinases
(such as BMS777607) would allow AC tethering, but prevent
downstream signaling necessary for phagocytosis and
TAM-mediated suppression of pro-inflammatory cytokine
production.17 In contrast, some Mer antibodies would be
predicted to block AC tethering and phagocytosis by binding
directly to receptor sites involved in TAM ligand recognition.
Certain of these ligand-blocking Mer antibodies can none-
theless exert agonistic effects on Mer tyrosine kinase activity,
presumably through their ability to crosslink the receptor.17
Thus, TAM-dependent anti-inflammatory signaling could be
preserved in the absence of AC tethering/phagocytosis. The
high levels of PtdSer exposure on ACs may make it difficult to
achieve effective blockade of AC opsonization with TAM
ligands, despite the extremely rapid binding to exposed
PtdSer. However, we have recently demonstrated that Gla-
less Gas6 retains the capacity to bind to TAM receptors, but is
seriously compromised with respect to activation of TAM
kinase activity.24 Thus, Gla-less TAM ligands may competi-
tively inhibit TAM-dependent AC tethering and differ from
antibodies and small-molecule TAM kinase inhibitors in their
mode of action. Our observations may facilitate new
approaches to therapeutic modulation of Mer function either
in homeostasis or in disease. Separation of the contribution of
these two processes is important, as in vitro studies have
demonstrated that interaction of macrophages with ACs
without engulfment can confer AC-induced anti-inflammatory
effects.60 Importantly, although Mer kinase activity is not
necessary for tethering, the Mer tyrosine kinase is none-
theless probably activated at the tethering stage.
In summary, we show that Mer has dual activities and can
function as a mediator of both AC tethering and subsequent
phagocytosis. Our definition of the molecular mechanisms
underlying phagocyte-AC interactions may provide opportu-
nities to identify novel targets for the restoration of defective
AC clearance associated with the development of inflamma-
tory disease and autoimmunity.
Materials and Methods
Reagents. Reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA)
unless otherwise stated. DMEM and Iscove’s DMEM (IDMEM) were from Invitrogen
(Carlsbad, CA, USA). Human Protein S was obtained from Enzyme Research
Laboratories (South Bend, IN, USA). Recombinant mouse Gas6 (full-length and
Gla-less) was prepared as previously described.24,48 BMS777607 was obtained
from Selleckchem (Houston, TX, USA). Goat polyclonal antibodies against human
Mer and mouse Mer and Axl and were obtained from R&D Systems (Minneapolis,
MN, USA). Monoclonal anti-human Mer (mouse IgG1) was from R&D Systems, anti-
GAPDH (mouse IgG1) was from Millipore (Billerica, MA, USA), anti-mouse CD61
mAb (Hamster, Hmbeta 3.1) and TIM4 (Rat IgG2a – clone 54) were obtained from
eBioscience (San Diego, CA, USA). Control immunoglobulins, and secondary HRP
or fluorescent-conjugated antibodies were from DAKO (Carpinteria, CA, USA). All
antibodies were titrated on cells or cell lines known to express the antigen.
Enhanced chemiluminescence (ECL) substrate and Hyperfilm was obtained from
GE Healthcare (Pittsburgh, PA, USA).
Cell isolation and culture. Human blood monocytes and PMN leukocytes
were isolated and cultured as described.23 Ethical approval for blood cell isolation
was obtained from the Lothian Research Ethics Committee (#08/S1103/38 or
#1702/95/4/72) at the Queen's Medical Research Institute, University of Edinburgh.
All healthy volunteers provided informed written consent. In brief, erythrocytes were
sedimented from freshly drawn peripheral blood with 0.6% (w/v) dextran T500
followed by fractionation of leukocytes on a discontinuous Percoll gradient (prepared
in Ca2+/Mg2+-free phPBS with final concentrations of Percoll of 50, 63, and 73%) at
720 g for 20 min. Mononuclear cells (MNC) were aspirated from the 50/63 interface,
and PMN from the 63/73% interface, and washed three times in PBS (without
Ca2+/Mg2+) before culture. Autologous platelet-rich plasma-derived ‘serum’ was
obtained by addition of CaCl2 (20 mM final) to platelet-rich plasma and incubation in
a glass tube for 1 h at 37 °C. MNC were plated at 4 × 106/ml in IDMEM and
incubated for 45–60 min, at 37 °C, 5% CO2 after which non adherent lymphocytes
removed by washing with HBSS (without Ca2+/Mg2+). Alternatively, monocytes were
isolated by negative selection using monocyte isolation kit II as specified by the
manufacturer (Miltenyi Biotech, Bisley, Surrey, UK) and plated at 6 × 105 cells/ml.
Monocytes were cultured for a period of 5–7 days in IDMEM containing 10%
autologous serum, with or without the addition of 250 nM (Dex) as detailed in the
figure legends, PMN (resuspended at 4x106 cells/ml in IDMEM containing 1% BSA)
were cultured at 37 °C in a 5% CO2 atmosphere for 20 h in Falcon tissue culture
flasks (BD Biosciences, San Jose, CA, USA). Cultured PMN populations were
routinely460% apoptotic, as determined by morphological analysis and Annexin V
binding, and o5% propidium iodide positive. Mouse BMDM were prepared from
wild-type C57bl/6 or TAM-knockout mice35 bred and housed at the Salk Institute
Animal Facility and cultured for 6–9 days as described.17,61 The Mertk−/− mice used
in this study are the Mer kinase-dead mutants reported by Camenisch et al.62
Although these mice express a low level of a truncated mRNA,35 the truncated Mer
protein is not stable and they are therefore effectively complete Mer protein
knockouts.33,63 In brief, tibias and femurs from 6- to 8-week-old mice were flushed
with sterile PBS (Mediatech Corning, Manassas, VA, USA), and red blood cells
were lysed with ACK lysis buffer using the manufacturer's protocol (Lonza,
Walkersville, MD, USA). Bone marrow cells were plated on Petri dishes in DMEM
supplemented with 10% FBS, antibiotics and 20% L929 supernatant as a source of
macrophage colony-stimulating factor. Fresh differentiation media was added on day
4 and macrophages were used on day 7–8. For treatment with glucocorticoids,
macrophages were incubated for 24 h with Dex (100 nM). In some experiments,
macrophages were treated for 24 h with LPS (100 ng/ml) or LPS in combination with
sphingosine-1-phosphate (1 μM), adenosine A2AR agonist (CGS21680, 10 μM),
immune complexes (biotinylated BSA mixed with mouse anti-biotin IgG1, 40 μg/ml
final IgG concentration), or 100 nM Dex. Mouse thymocytes were isolated by
mechanically disrupting the thymus with 19-G needles followed by lysis of red blood
cells with ACK lysis buffer. Thymocytes were cultured for 6 h in DMEM/10% FCS
containing 5 × 10-7M Dex to induce apoptosis (64± 8.2% Annexin V+, n= 11).
Macrophage tethering and phagocytosis of ACs. Macrophage
phagocytosis of labeled ACs was assessed by flow cytometry as
described,17,64,65 using cells that had been washed extensively to remove all
possible exogenous TAM ligands or soluble TAM receptors. BMDM (mouse) or
monocyte-derived macrophages from blood (human) were overlaid with ACs that
had been labeled either with 5-chloromethylfluorescein diacetate (CMFDA) or
pHrodo. After co-culture for 30 min at 37 °C, non-ingested ACs were removed by
Mer-mediated tethering and phagocytosis of ACs
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aspiration of media and cells detached by addition of 0.25% trypsin containing 1 mM
EDTA for 5 min at 37 °C followed by vigorous pipetting. The percentage of
macrophages that were fluorescent was then determined by flow cytometric
analysis as described below. For assessment of AC tethering, macrophages were
overlaid with CMFDA-labeled ACs (phagocyte:target ratio of 1 : 5) and incubated at
4 °C for 30–60 min. Macrophage monolayers were washed three times in DMEM,
fixed with 2.5% paraformaldehyde and counter-stained with rhodamine phalloidin.
For quantification of tethering, we used a modification of a well-characterized
microscopy-based assay for phagocytosis.66 If an AC target was observed to be
within the membrane of a macrophage, it was recorded as being internalized,
whereas AC tethering was identified by the presence of ACs directly adjacent to
macrophage membrane. This method of quantification was validated by
confirmation that tethered AC targets remained accessible to an antibody, whereas
internalized ACs were not (data not shown). For experiments using the inhibitor
BMS777607, a similar analysis was undertaken to assess the effect of BMS777607
on particle tethering or internalization. In these experiments, macrophages were
washed once then pre-incubated for 15 min with 300 nM BMS777607 before co-
incubation with AC targets at either 4 or 37 °C. The percentage of macrophages
associated with targets was quantified microscopically (4500 cells in randomly
selected fields per well) and an average between duplicate wells calculated.
Labeling of proteins. Proteins were labeled with DyLight-488 N-hydroxy-
succinimide ester as recommended by the manufacturer (Pierce, Rockford, IL,
USA). In brief, protein to be labeled (at 1.0–1.2 mg/ml) was exchanged into 100 mM
boric acid, 25 mM sodium borate and 70 mM NaCl (pH8.4) and incubated with a
10-fold molar excess of DyLight-488 (stock prepared in dimethylformamide). After
labeling for 30–60 min in the dark at room temperature, the reaction was terminated
by addition of glycine to a final concentration of 50 mM and then protein was buffer
exchanged into PBS. The degree of protein labeling was estimated from
measurement of absorbance at 280 and 493 nm and was routinely between 2.5
and 3.5 moles of dye/mole of protein. Alternatively, proteins were labeled with Cy5,
exchanging protein to be labeled (at 1.0–1.2 mg/ml) into 100 mM sodium hydrogen
carbonate buffer (pH8.8) and incubated with Cy5 mono-reactive dye pack for 30 min
in the dark at room temperature as recommended by the manufacturer (GE
Healthcare). After termination of the reaction by addition of glycine to a final
concentration of 50 mM, protein was buffer exchanged into PBS using protein
desalting spin columns (Pierce). The degree of protein labeling was estimated from
measurement of absorbance at 280 and 493 nm (Dylight 488) or 280 and 650 nm
(Cy5) and was routinely found to be between 2.5 and 3.5 moles of dye/mole of
protein. Functionality of labeled protein was assessed by testing the potential to
induce Mer phosphorylation and the capacity to confer Mer-dependent phagocytosis
of ACs (data not shown).
Flow cytometry. Indirect immunofluorescence analysis was performed as
described67 with all incubations carried out on ice to prevent internalization of bound
antibody. Macrophages were detached from tissue culture plastic by incubation in
PBS containing 2 mM EDTA and 0.5% serum for 10–20 min. After washing with ice-
cold PBS containing 0.2% (w/v) bovine serum albumin and 0.1% (w/v) sodium azide
(PBN), cells (105/assay) were labeled following blocking of non-specific binding of
antibodies to Fc with 20% (v/v) normal rabbit serum or FcR block (eBioscience).
Cells were then incubated with saturating concentrations of goat anti-mouse Mer
antibody for 30 min and washed twice in PBN before incubation with FITC- or APC-
conjugated anti-goat immunoglobulin (DAKO) for 30 min and washed twice more
before analysis. For some experiments, macrophages were further labeled with PE-
conjugated anti-TIM-4 or appropriate rat IgG2b isotype control. For TAM ligand
binding, apoptotic mouse thymocytes or apoptotic human neutrophils were incubated
with saturating concentrations of fluorescently labeled TAM ligands diluted in 20 mM
HEPES pH7.4 containing 0.14 M NaCl with or without the addition of 2 mM CaCl2 on
ice. For some experiments, apoptotic cells were co-incubated with PE-conjugated
Annexin V. Data acquisition was carried out using an LSRII or FACSCalibur flow
cytometer (BD Biosciences) with post-acquisition data analysis with either Cellquest
(BD Biosciences) or Flowjo software (Flowjo, Ashland, OR, USA).
Scanning electron microscopy. Monocytes were cultured adherent to
clean glass coverslips in DMEM containing 10% autologous serum and 250 nM Dex
for 5 days before washing in PBS and fixation in 3% glutaraldehyde in sodium
cacodylate buffer (0.1 M, pH 7.4) for 3 h. Coverslips were washed three times in
sodium cacodylate buffer (0.1 M, pH 7.4) for 20 min each and transferred to osmium
tetroxide (1% v v-1) in sodium cacodylate buffer (0.1 M, pH 7.4) for 1 h. Following a
30-min wash in distilled water, samples were dehydrated by sequential washes in
increasing concentrations of acetone for 1 h each (50, 70, 90%), followed by three
washes in acetone (100%) for 1 h each. Critical point drying with carbon dioxide was
carried out and samples had a sputter coating of gold:palladium (20 nm, 60/40)
added before viewing with a Philips 505 scanning electron microscope.
Western blot analysis. Cells were lysed for 15 min on ice in PBS containing
1% NP-40, 0.1 mM NaVO3, and protease inhibitor cocktail (Roche, Mannheim,
Germany) before centrifugation at 14 000 × g, 4 °C, 20 min. The resulting lysates
were tested for protein concentration using a detergent compatible protein
estimation kit (Pierce) and equilibrated to contain equivalent levels of protein (10–
15 μg total protein) and resolved using a 9% reducing SDS–PAGE. Proteins were
transferred to PVDF membranes, which were then blocked with TBS containing
0.05% Tween-20 and 5% skim milk (w/v) before probing with antibodies. Bound
antibodies were visualized with enhanced chemiluminescence as described by the
manufacturer.
Statistics. Results are presented as mean± S.D. where n= number of
independent experiments using cells obtained from different donors or mice and
significance analyzed by ANOVA with Mann–Whitney post-test using Instat software
(Graphpad, San Diego, CA, USA).
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